10 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18568738 | COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME | FETTEROLF, BRANDON J | 1626 | Non-Final OA | Dec 08, 2023 |
| 18288318 | PURINE NUCLEOSIDES, THEIR INTERMEDIATES, AND METHODS OF PREPARATION THEREOF | SEAMAN, D MARGARET M | 1625 | Non-Final OA | Oct 25, 2023 |
| 18199776 | INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS | BRAUN, MADELINE E | 1624 | Non-Final OA | May 19, 2023 |
| 18318588 | USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS | STOICA, ELLY GERALD | 1647 | Non-Final OA | May 16, 2023 |
| 18032132 | HIGH CONCENTRATION METHYLCOBALAMIN OR COMBINATION OF METHYL- AND HYDROXY-COBALAMIN FOR THE TREATMENT OF COBALAMIN C DEFICIENCY DISORDERS | CRAIGO, BAHAR ALAWI | 1699 | Non-Final OA | Apr 14, 2023 |
| 18053308 | ANTISENSE THERAPEUTICS FOR BETACORONAVIRUS TREATMENT | BEANE, RANDALL L | 1654 | Non-Final OA | Nov 07, 2022 |
| 17923394 | ABERRANT POST-TRANSLATIONAL MODIFICATIONS (PTMS) IN METHYL- AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS | BOWLES, DAVID PAUL | 1654 | Non-Final OA | Nov 04, 2022 |
| 17783171 | ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF | PETERS, ALEC JON | 1641 | Final Rejection | Jun 07, 2022 |
| 17674378 | INTRACELLULAR GENOMIC TRANSPLANT AND METHODS OF THERAPY | LEONARD, ARTHUR S | 1631 | Final Rejection | Feb 17, 2022 |
| 17346630 | METHODS TO ELIMINATE CANCER STEM CELLS BY TARGETING CD47 | MATALKAH, FATIMAH KHALAF | 1638 | Final Rejection | Jun 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial